Related Experiment Video
Updated: Nov 17, 2025

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
Novel Approaches to Epigenetic Therapies: From Drug Combinations to Epigenetic Editing
Aleksandra Majchrzak-Celińska1, Anna Warych1, Mikołaj Szoszkiewicz1
1Department of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, 60-781 Poznań, Poland.
Abstract:
Cancer development involves both genetic and epigenetic alterations. Aberrant epigenetic modifications are reversible, allowing excellent opportunities for therapeutic intervention. Nowadays, several epigenetic drugs are used worldwide to treat, e.g., myelodysplastic syndromes and leukemias. However, overcoming resistance and widening the therapeutic profiles are the most important challenges faced by traditional epigenetic drugs. Recently, novel approaches to epigenetic therapies have been proposed. Next-generation epigenetic drugs, with longer half-life and better bioavailability, are being developed and tested. Since epigenetic phenomena are interdependent, treatment modalities include co-administration of two different epigenetic drugs. In order to sensitize cancer cells to chemotherapy, epigenetic drugs are administered prior to chemotherapy, or both epigenetic drug and chemotherapy are used together to achieve synergistic effects and maximize treatment efficacy. The combinations of epigenetic drug with immunotherapy are being tested, because they have proved to enhance antitumor immune responses. The next approach involves targeting the metabolic causes of epigenetic changes, i.e., enzymes which, when mutated, produce oncometabolites. Finally, epigenome editing makes it possible to modify individual chromatin marks at a defined region with unprecedented specificity and efficiency. This review summarizes the above attempts in fulfilling the promise of epigenetic drugs in the effective cancer treatment.
Insights
Epigenetic drugs offer reversible cancer treatment strategies. Novel approaches, including drug combinations and epigenome editing, aim to overcome resistance and enhance efficacy for improved cancer therapy.
Area of Science:
- Oncology
- Epigenetics
- Pharmacology
Background:
- Cancer arises from genetic and epigenetic changes.
- Epigenetic modifications are reversible, presenting therapeutic opportunities.
- Current epigenetic drugs face challenges like resistance and limited therapeutic scope.
Purpose of the Study:
- To review emerging epigenetic drug strategies for cancer treatment.
- To highlight advancements in overcoming limitations of traditional epigenetic therapies.
- To explore novel approaches for enhanced cancer therapy.
Main Methods:
- Review of next-generation epigenetic drugs with improved pharmacokinetic properties.
- Analysis of combination therapies: epigenetic drugs with chemotherapy or immunotherapy.
- Exploration of targeting metabolic pathways driving epigenetic alterations.
- Discussion of epigenome editing for precise chromatin modification.
Main Results:
- Next-generation epigenetic drugs show promise for better bioavailability and half-life.
- Combination therapies (epigenetic + chemotherapy/immunotherapy) demonstrate synergistic effects and enhanced antitumor responses.
- Targeting metabolic pathways offers a new avenue for epigenetic intervention.
- Epigenome editing provides high specificity for chromatin mark modification.
Conclusions:
- Novel epigenetic therapies, including combinations and epigenome editing, are advancing cancer treatment.
- These strategies aim to enhance efficacy, overcome resistance, and broaden therapeutic applications.
- Targeting metabolic causes and precise epigenome editing represent significant progress in epigenetic drug development.
More Related Videos
07:49CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery
Published on: May 30, 2025
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
CRISPR
Methods of Nuclear Reprogramming
Microorganisms in Medicine and Therapeutics